Ergoteles’s Albemarle ALB Stock Holding History

Ergoteles’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-25,084	Closed	-$4.23M	–	1163
2021 Q2	$4.23M	Buy	+25,084	New	+$4.05M	0.1%	251
2020 Q4	–	Sell	-2,400	Closed	-$214K	–	650
2020 Q3	$214K	Buy	+2,400	New	+$213K	0.03%	455

Other funds holding ALB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles's ALB Position: Q3 2021 in Review

Ergoteles sold out of Albemarle (ALB) in Q3 2021, closing a stake of 25,084 shares — an estimated $4.23M sold.

Ergoteles first reported a position in ALB in Q3 2020 and held it in 2 quarters. The position peaked at $4.23M in Q2 2021. 795 funds tracked by Wall St. Rank hold ALB as of Q3 2021.

Ergoteles reported no remaining Albemarle position as of Q3 2021 after selling out during the quarter.
Ergoteles sold 25,084 Albemarle shares in Q3 2021, an estimated $4.23M.
Ergoteles first reported a position in Albemarle in Q3 2020 and held it in 2 quarters.
Ergoteles's Albemarle position peaked at $4.23M in Q2 2021.
795 funds tracked by Wall St. Rank held Albemarle as of Q3 2021.

Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.